The FDA just changed the game for peptides. April 2026 The FDA is reviewing Category 2 peptides for potential removal from restricted status. Full approval for some peptides may be FDA to Review 7 Peptides for Compounding List in July 2026: BPC 157, Semax, Epitalon, and More HealingMaps FDA July 2026 Peptide Meeting: What Patients Need to Know About Access, Approval, and Safety Meto blog Is BPC 157 Banned? Oral vs. Injectable Forms Explained The FDA just put BPC 157 on the calendar. July 2324 advisory panel votes on whether to restore legal compounding access for BPC 157, TB 500, and 5 more restricted peptides. This is the BPC 157: A MAHA Adjacent Peptide, Linked to Croatia